🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a prospective, observational clinical trial designed to evalu...
Status
Completed
Location
Asan Medical Center
Start Date
2018-08-21
Trial ID
NCT07160374
Treatments Being Tested
This multicenter retrospective study evaluated consecutive patients with la...
Status
Completed
Location
The Second Affiliated Hospital of Guangzhou Medical University
Start Date
2019-07-01
Trial ID
NCT06265883
Treatments Being Tested
Vast majority of patients with hepatocellular carcinoma (HCC) present with ...
Status
Unknown
Location
Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre
Start Date
2014-12
Trial ID
NCT02794337
This trial is a multi-center, phase III, randomized (1:1) clinical trial. T...
Status
Unknown
Location
The First Affiliated Hospital of Sun Yat-sen University
Start Date
2019-09-15
Trial ID
NCT04143191
Treatments Being Tested
Hepatocellular carcinoma (HCC) is the fourth most common cancer in China, w...
Status
Unknown
Location
Beijing Ditan Hospital, Capital Medical University
Start Date
2019-09-01
Trial ID
NCT04127396
Hepatocellular carcinoma (HCC) is listed as the sixth most common cancer wo...
Status
Unknown
Location
Sohag University Hospital
Start Date
2022-01-01
Trial ID
NCT05093920
Treatments Being Tested
This study is conducted to evaluate the efficacy and safety of lenvatinib p...
Status
Recruiting
Location
The Second Affiliated Hospital of Guangzhou Medical University
Start Date
2025-04-01
Trial ID
NCT06904183
Treatments Being Tested
This study will evaluate the safety and efficacy of DEB-TACE with visualabl...
Status
Recruiting
Location
Peking University First Hospital
Start Date
2023-12-19
Trial ID
NCT06190665
Treatments Being Tested
Cadonilimab is a first-in-class bispecific, humanized IgG1 antibody targeti...
Status
Unknown
Location
Eastern hepatobilliary surgery hospital
Start Date
2023-04-24
Trial ID
NCT05925413
Treatments Being Tested
This is a multicentri prospective cohort study to investigate the safety an...
Status
Withdrawn
Location
The First Affiliated Hospital of Sun Yat-sen University
Start Date
2018-10-01
Trial ID
NCT05592197
Treatments Being Tested